Cardiff Oncology (CRDF) Non-Current Assets (2011 - 2026)
Cardiff Oncology (CRDF) recorded Non-Current Assets of $1.74 million in Q2 2026, down 15.0% from $2.04 million a year earlier.
Analysis
Cardiff Oncology (CRDF) Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Cardiff Oncology reported Non-Current Assets of $1.76 million, down 17.8% from FY2024.
- Annual Non-Current Assets has declined for three straight years, though with a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $2.14 million in FY2024 (-49.4%), $4.23 million in FY2023 (-13.9%), $4.91 million in FY2022 (+43.6%) and $3.42 million in FY2021 (+149.2%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q2 2021.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 345.8% in Q2 2022, against a decline of 49.4% in Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Cardiff Oncology | 63.71 Mn | 29.21 Mn | - | 1.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 4.23 Mn |
| Sep 30, 2023 | 4.55 Mn |
| Jun 30, 2023 | 4.72 Mn |
| Mar 31, 2023 | 4.80 Mn |
| Dec 31, 2022 | 4.91 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Jun 30, 2022 | 3.85 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 3.42 Mn |
| Sep 30, 2021 | 3.54 Mn |
| Jun 30, 2021 | 863,000.00 |
API Access
Cardiff Oncology Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CRDF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();